Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free
Accelerate Diagnostics NASDAQ AXDX
$0.93 -0.02 -1.63%
Today share price
USA
Sector: Healthcare Industry: Life Sciences Tools & Services
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 19 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

13.55M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
39.80M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.88
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
14.57M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-76.27 %
Upcoming events Accelerate Diagnostics All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart Accelerate Diagnostics

Stock analysis Accelerate Diagnostics

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.24 27.67
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
-0.68 5.21
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-0.82 22.73
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-0.54 0.47
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
281.66 13.20

Price change Accelerate Diagnostics per year

5.15$ 15.60$
Min Max

Summary analysis Accelerate Diagnostics

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Accelerate Diagnostics

Revenue and net income Accelerate Diagnostics

All parameters
Stock news Accelerate Diagnostics All news
19 January в 18:00

Accelerate Diagnostics Shares Plumb New Depths on Stock Sale

19 January в 17:55

Accelerate Diagnostics Shares Plumb New Depths on Stock Sale

16 January в 16:05

Accelerate Diagnostics Shares Slide Premarket on Stock Offering Plans

16 January в 16:00

Accelerate Diagnostics Shares Slide Premarket on Stock Offering Plans

9 January 2023 в 17:50

SomaLogic Exploring Strategic Alternatives to Accelerate Diagnostics Growth

9 January 2023 в 17:50

SomaLogic Exploring Strategic Alternatives to Accelerate Diagnostics Growth

19 August 2022 в 22:05

Accelerate Diagnostics Shares Fall 40% After Public Offering Prices

19 August 2022 в 22:01

Accelerate Diagnostics Shares Fall 40% After Public Offering Prices

18 August 2022 в 18:31

Accelerate Diagnostics Shares Fall After Proposed Public Offering

18 August 2022 в 18:31

Accelerate Diagnostics Shares Fall After Proposed Public Offering

About company Accelerate Diagnostics

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is headquartered in Tucson, Arizona.
Address:
3950 South Country Club Road, Tucson, AZ, United States, 85714
Company name: Accelerate Diagnostics
Issuer ticker: AXDX
ISIN: US00430H1023
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 1996-11-18
Sector: Healthcare
Industry: Life Sciences Tools & Services
Site: https://acceleratediagnostics.com

On which stock exchange are Accelerate Diagnostics (AXDX) stocks traded?

Accelerate Diagnostics (AXDX) stocks are traded on NASDAQ.

What is the ticker of Accelerate Diagnostics stocks (AXDX)?

The stock ticker of Accelerate Diagnostics’s stocks or in other words, the code is AXDX. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Accelerate Diagnostics (AXDX) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Accelerate Diagnostics (AXDX) belongs to the «Healthcare» sector and the «Life Sciences Tools & Services» industry.

In what currency are Accelerate Diagnostics (AXDX) stocks traded?

Accelerate Diagnostics (AXDX) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Accelerate Diagnostics (AXDX) stocks today?

The current price of Accelerate Diagnostics stocks on 29.04.2024 is 0.9301 dollars. per share.

What is the dynamics of Accelerate Diagnostics (AXDX) stocks from the beginning of the year?

Accelerate Diagnostics (AXDX) quotes have increased by -78.01% from the beginning of the year up to 0.9301 dollars. per 1 stocks.

How much did Accelerate Diagnostics (AXDX) stocks increase in апреле 2024?

This month Accelerate Diagnostics (AXDX) quotes have increased by 4.56% to 0.9301 dollars. per share.

How much are Accelerate Diagnostics (AXDX) stocks worth?

Today, on October, 29.04.2024 Accelerate Diagnostics’s (AXDX) stocks cost 0.9301 dollars..

What is the market capitalization of Accelerate Diagnostics (AXDX)?

Capitalization is the market value of Accelerate Diagnostics (AXDX) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 29.04.2024, the market capitalization of Accelerate Diagnostics (AXDX) is estimated at about 13551092 dollars.